Dong Sung Bio Pharm.Co.,Ltd. financial statements

동성제약KRX:002210 · KOSPI · Healthcare · sector #23
₩1,293+0.70%
2026-10-07 close

Dong Sung Bio Pharm.Co.,Ltd.'s published financial data is dated 2026-10-04. 2024 revenue was KRW 88.45B. 2024 operating profit was −KRW 6.63B.

Reported results

Dong Sung Bio Pharm.Co.,Ltd. notifications

Quantus Signal · live data · not investment advice · Privacy Policy